Physician profile
Charissa Farris
NPI 1023227733
$8,209.59
in general payments reported to CMS, 2019-2025
23 companies · $18.05 in 2025
The $18.05 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,774 · 2020: $812 · 2021: $4,780 · 2022: $786 · 2023: $39.71 · 2025: $18.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,978.56 | 2021-2022 | |
| Arthrex, INC. | $1,417.00 | 2021 | |
| Impactortho, INC. | $1,285.64 | 2021 | |
| Stryker Corporation | $1,175.17 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $763.27 | 2020-2021 | |
| Amgen INC. | $247.82 | 2021 | |
| Zimmer Biomet Holdings, INC. | $241.76 | 2019-2020 | |
| Depuy Synthes Sales INC. | $197.72 | 2019-2021 | |
| Medtronic USA, INC. | $174.38 | 2019 | |
| Smith+Nephew, INC. | $168.71 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $124.59 | 2019 | |
| Osiris Therapeutics INC. | $123.29 | 2019 | |
| Boston Scientific Corporation | $78.04 | 2021-2025 | Wavewriter Alpha Prime 16, Accolade Sr |
| Abbvie INC. | $51.47 | 2021 | |
| Medtronic, INC. | $35.05 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $34.42 | 2022-2023 | |
| Pfizer INC. | $21.49 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.47 | 2021 | |
| Novo Nordisk INC | $18.43 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.53 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.57 | 2021 | |
| Clarus Therapeutics INC. | $13.32 | 2021 | |
| Horizon Therapeutics Plc | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charissa Farris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.